물품대금
1. The Defendants jointly and severally agreed with the Plaintiff KRW 95,598,250 and 6% per annum from May 3, 2019 to June 24, 2019.
Comprehensively taking account of the overall purport of the arguments as to Gap evidence Nos. 1 through 4, the Plaintiff may recognize the fact that from September 20, 2018 to April 30, 2019, the Plaintiff supplied drugs equivalent to KRW 121,18,250 in total to the defendants who are joint business operators of the "F Pharmacy" located in Dongjak-gu Seoul Metropolitan Government E, and received reimbursement of KRW 25,590,000 out of the above payment until May 2, 2019.
According to the above, the Defendants are jointly and severally liable to pay to the Plaintiff the remaining amount of KRW 95,598,250 (i.e., KRW 121,18,250 - KRW 25,590,00) and damages for delay calculated at each rate of 12% per annum under the Commercial Act from May 3, 2019 to June 24, 2019, which is clearly indicated that the delivery date of a copy of the instant complaint is the delivery date of the instant complaint, as sought by the Plaintiff. Accordingly, the Defendants are jointly and severally liable to pay to the Plaintiff the damages for delay calculated at each rate of 95,598,250 won per annum from the next day to the day of full payment. Accordingly, the Plaintiff’s claims against the Defendants are accepted